Seres Therapeutics, Inc.MCRBNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank77
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Latest
22.54%
↑ 231% vs avg
Percentile
P77
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
-17.19%
Historical baseline
PeriodValue
202522.54%
202437.82%
2023-8.44%
2022-178.97%
202126.82%
2020-22.61%
201928.33%
2018-9.73%
20171.56%
2016-69.24%